J2356 HCPCS code: Injection, tezepelumab-ekko, 1 mg
J2356 is the HCPCS Level II code for injection, tezepelumab-ekko, 1 mg. In 2024 Medicare paid an average of $14.05 per service for J2356 across 9,050,770 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 210 per day on outpatient hospital claims. Medicare volume rose 594% from 2022 to 2024 (1,303,663 to 9,050,770 services). In 2024, about 2,649 clinicians billed Medicare for J2356 for 5,759 beneficiaries; Florida, Texas, California accounted for 35% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-07-01 |
| Last action effective | 2022-07-01 |
Who bills J2356 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,649 |
| Medicare beneficiaries | 5,759 |
| States with claims | 43 |
| Share of services in top 3 states (Florida, Texas, California) | 35% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2356, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,303,663 | 1,767 | $17.45 | $13.90 |
| 2023 | 5,527,823 | 4,044 | $17.73 | $14.12 |
| 2024 | 9,050,770 | 5,759 | $17.66 | $14.05 |
States with the most J2356 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 1,250,616 | $14.13 |
| Texas | 954,399 | $14.12 |
| California | 909,008 | $13.74 |
| Tennessee | 413,712 | $14.11 |
| Virginia | 337,686 | $14.08 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 210 | Prescribing Information |
| practitioner claims | 210 | Prescribing Information |
What changed for J2356
- 2022-07-01: J2356 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2356?
J2356 is the HCPCS Level II code for injection, tezepelumab-ekko, 1 mg. Short descriptor: "Inj tezepelumab-ekko, 1mg".
How much does Medicare pay for J2356?
In 2024, the average Medicare payment was $14.05 per service (average allowed $17.66).
Does Medicare cover J2356?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2356 can be billed per day?
210 on outpatient hospital claims; 210 on practitioner claims (NCCI medically unlikely edits).
Related J23 codes
- J2300 — Injection, nalbuphine hydrochloride, per 10 mg
- J2305 — Injection, nitroglycerin, 5 mg
- J2310 — Injection, naloxone hydrochloride, per 1 mg
- J2311 — Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312 — Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313 — Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315 — Injection, naltrexone, depot form, 1 mg
- J2320 — Injection, nandrolone decanoate, up to 50 mg
- J2323 — Injection, natalizumab, 1 mg
- J2325 — Injection, nesiritide, 0.1 mg
- J2326 — Injection, nusinersen, 0.1 mg
- J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2356
- Watch J2356 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2356
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.